What is the role of upfront pembrolizumab in metastatic PD-L1 positive NSCLC presenting with SVC syndrome?
Would starting with chemotherapy be preferred in this situation and consider concurrent radiation, then switch over to Pembrolizumab once some control is achieved?
Answer from: Medical Oncologist at Academic Institution
This is a "trick question" as there are at least 3 difficult questions hidden here-
Can systemic therapy replace the need for local therapy in urgent clinical situations traditionally calling for radiation?
What is the best upfront treatment regimen for a patient with PD-L1 positive NSCLC?
What i...
Comments
Medical Oncologist at Einstein Medical Center Philadelphia Thank you @Balazs Halmos and @Nitin Ohri, ver...
Medical Oncologist at UNC/Rex Healthcare Thank you both! Great Discussion!!
Medical Oncologist at Dayton Physicians Network Hematology Thank you Dr Halmos and Dr Ohri for such an excell...
Thank you @Balazs Halmos and @Nitin Ohri, ver...
Thank you both! Great Discussion!!
Thank you Dr Halmos and Dr Ohri for such an excell...